Latest News
14
2023
Sep
Greenyn Biotechnology Receives Five Gold Medals at South Korea WiC and U.S. AII Da Vinci International and Invention Expo
The best-selling Bitter Melon Extract from Greenyn Biotechnology (6846) is celebrating more success. After winning the South Korean World Invention Innovation Contest WiC, it won the AII American Da Vinci International Innovation and Invention Expo, receiving international fame. This achievement supports Taiwanese brand clients expanding globally.
The unique small-molecule sequenced peptide "Insumate® patented amino peptide sequence mcIRBP-19" weighs 2,162 Da. Mechanism validation and scientific studies show it promotes metabolism, regulates physiological activities, and maintains health for refined diet eaters. It's the first Bitter Melon Extract product to achieve FDA New Dietary Ingredients (NDI 1256) approval. This double gold from South Korea and the US reinforces Bitter Melon Extract's industry leadership.
In addition, "Antromax® Antrodia Cinnammomea Mycelium" utilizes specific strain acclimatization, patented culture medium, and scientific production control to shorten the growth cycle of A. cinnammomea. This process allows for the commercialization of its valuable triterpenoid components as a health supplement. Emphasizing environmental sustainability, it eliminates the need for rare wood-based substrates, saving space, reducing costs, and lowering the carbon footprint. It has not only won double gold awards but also received special recognition at the South Korea WiC contest.
Greenyn has revolutionized agricultural research by adopting a high-tech, eco-friendly approach to cultivate Taiwan's unique wild vegetable, Crassocephalum rabens, aiming to address the land and water consumption issues associated with heavy agricultural machinery. This method significantly increases key component content, surpassing wild species by tenfold. Through innovative use of supercritical fluid technology, Greenyn has created plant extracts, "RabenWhite® Crassocephalum rabens extract (containing CRK774)" and "RabenLiv® Crassocephalum rabens extract (containing HCP774)," both awarded gold at the South Korea WiC contest.
Since its inception, Greenyn Biotechnology has achieved more than 80 international patents and over 10 prestigious international invention awards. This outstanding performance on the global stage not only affirms Greenyn's R&D capabilities but also underscores the company's commitment to sustainable environmental practices. It signifies a promising future for the health supplement industry. Moving forward, Greenyn Biotechnology will continue to dedicate itself to providing top-quality health supplement ingredients for global customers, driving both human health and environmental conservation efforts. Together, we strive towards a thriving and active lifestyle for all.
News URL
1.yahoo!新聞
2.LINE TODAY
3.理財周刊
4.台灣產經新聞網
5.新頭條
